ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

More Patients Get Screened, Colorectal Death Rates Drop

July 29, 2011

UICC Announces Grant Programs to Continue

April 15, 1977

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Prevention Program Being Developed For Primary Providers

January 29, 1988

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

February 19, 2010